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Abstract
Gonadotropin releasing hormone (GnRH) is the master regulatory hormone for
sexual development. During embryonic development, gonadotropin releasing hormone-1
neurons (GnRH-1ns) form in the olfactory pit and migrate, along axonal Peripherin
positive fibers, from the nasal area to the pre-optic area of the basal forebrain. Upon
migration into the brain, GnRH-1ns release GnRH. Defective migration of GnRH-1ns can
result in hypogonadotropic hypogonadism (HH), a condition that results in lack of sexual
development and infertility. When HH appears associated with reduced or absent sense
of smell, it is clinically defined as Kallmann Syndrome (KS) (Paolo E Forni & Wray,
2015). The neurons that connect the nasal area to the basal forebrain and the molecular
mechanisms that control GnRH-1 neuronal migration are still largely unknown. Sonic
hedgehog (Shh) plays important roles in modulating cell motility and reactivity to
chemorepellants. Gli3 is a transcriptional effector; it can act as either a transcriptional
activator or repressor, mediated by the Shh signaling pathway. We found that Patched2, a receptor for Shh, is expressed along the GnRH-1 migratory pathway. To understand
if Shh and Gli3 play a role in GnRH-1 development, we analyzed GnRH-1 migration in
Gli3Xt/Xt mouse mutants. In these mutants, we observed a dramatic reduction in the
number of GnRH-1ns able to migrate form the nasal area into the brain. In Gli3Xt/Xt
mutants, GnRH-1ns were found proximal to the vomeronasal organ forming tangles with
a subset of Peripherin positive fibers, which were found to extend as far as the forebrain
junction, where they also tangle in response to the lack of olfactory bulbs. Our data
suggests that the loss of function of the Gli3 gene impairs the formation of the GnRH-1
migratory scaffold and GnRH-1 migratory ability. These observations indicate that Gli3 is
a candidate gene for the etiology of HH.
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Introduction
GnRH-1 neurons are a fundamental part of the hypothalamic-pituitary-gonadal
(HPG) axis, controlling sexual development and reproductive hormone development
(Paolo E Forni & Wray, 2015). GnRH-1 neurons travel from the vomeronasal organ
(VNO) found in the olfactory pit to the pre-optic area of the basal forebrain where they
release signals to the hypothalamus allowing the secretion of hormones. Luteinizing
hormone (LH) and follicle stimulating hormone (FSH) secretion is elemental for
reproductive function. In the ovary, LH produces estrogen and in the testis, LH produces
testosterone. In males and females, FSH is necessary for the maturation of gametes
(Paolo E Forni & Wray, 2015). Therefore, defective migration of GnRH-1 neurons from
the olfactory pit results in hypogonadotropic hypogonadism (HH); HH is responsible for
adverse reproductive development. Difficulty perceiving odors (hyposmia) or the lack of
ability to smell (anosmia) associated with HH is clinically diagnosed as Kallman
Syndrome (KS).
Point mutations in Gli3 have been identified in humans affected by HH
(Vaaralahti et al., 2012). Gli3 acts as a transcriptional activator or repressor, mediated by
the sonic hedgehog (Shh) signaling pathway. When Shh is present, it binds to its
membrane-bound receptor, Patched-2, which then binds to a membrane-bound
molecule, Smoothened, activating the Shh pathway. This mechanism prevents the
phosphorylation and proteolytic cleavage of Gli3, and Gli3 acts as a transcriptional
activator. To study the potential role of aberrant Shh signaling pathway and a
nonfunctional Gli3 protein on GnRH-1 neuronal migration, we used a Gli3Xt/Xt mutant
mouse model. Gli3Xt/Xt mouse mutants have an intragenic deletion of the Gli3 gene that
results in a loss of function of GLI3. Gli3Xt/Xt mice exhibit a plethora of severe phenotypes
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including malformations of the brain, absence of the olfactory bulbs, and extra digits
(Extra toe (Xt)) (Vaaralahti et al., 2012).
It is commonly believed that the migratory scaffold upon which the GnRH-1ns
migrate is formed by axons of neurons of the olfactory system. However, unpublished
data generated in Forni lab suggest otherwise. In fact, in Arx-1 null mice, a mouse model
that lacks the olfactory bulbs and olfactory connection to the brain (Fulp et al., 2008),
GnRH-1ns were found able to normally migrate into the brain along neuronal fibers of
the putative terminal nerve (TN).
However, in the Gli3Xt/Xt mutants, we observed a complete loss of GnRH-1ns able
to access the brain, and a reduction in the total number of GnRH-1ns in the whole
animal. This suggests that the Gli3 mutation affects the projections of the terminal nerve,
disrupts normal GnRH-1 neuronal migration, and impairs normal GnRH-1 neurogenesis.
Gli3-null mutants do not survive past birth, as their severe brain malformations
restrict that. On the other hand, Gli3 heterozygotes are viable and fertile. They survive
past birth, occasionally with hydrocephaly, are able to reproduce, although some litters
were found to be smaller than average, and have an average life span. Heterozygotes
consistently have one extra toe and a small white spot on the belly in response to neural
crest defects.
Materials and Methods
Animals Used
Gli3Xt/Wt mice were received from The Jackson Laboratory. The olfactory defects
in Gli3Xt/Xt mice were previously characterized (Balmer & LaMantia, 2004). Gli3Xt/WT
heterozygotes on a C57 Black genetic background were mated. Animals were
euthanized using CO2, followed by cervical dislocation. All animal procedures were done
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in accordance with procedures approved by the University at Albany Institutional Animal
Care and USE Committee (IACUC).
Tissue
Embryos were collected from time mated Gli3Xt/Wt females where a copulation
plug was considered embryonic day 0.5 (E0.5). Embryos were fixed in 3.7%
formaldehyde/PBS overnight then washed in PBS to remove the fix. Embryos were
cryoprotected in 30% sucrose in PBS solution overnight. Embryos were embedded in
O.C.T (Tissue-Tek) that was frozen with dry ice and stored in -80°C. Samples were
cryosectioned using LEICA CM3050 S cryostat and collected on Superfrost plus slides
(VWR) at 14 µm.
Genotyping Mice/PCR
Genotypes of mice were determined first by visual observation of multiple toes
and confirmed doing PCR using the following primer sequences: wildtype forward primer
5’-GGCCCAAACATCTACCAACACATAG-3’;
GTTGGCTGCTGCATGAAGACTGAC-3’;
TACCCCAGCAGGAGACTCAGATTAG-3’;

wildtype
mutant
mutant

reverse
forward
reverse

primer

5’-

primer

5’-

primer

5’-

AAACCCGTGGCTCAGGACAAG-3’. Amplification products were analyzed by agarose
gel electrophoresis.
Immunohistochemistry (IHC)
Sections were first incubated in and 30% hydrogen peroxide solution for 30
minutes. Sections were put into blocking solution (10% Horse Serum, 1.1% BSA, 0.1%
Sodium Azide, 0.5% Triton in 200 mL 1x PBS) for 1-2 hours. Sections were incubated in
primary antibodies overnight. The primary αbodies that were used are rabbit (Rb) αPeripherin (1:500, Millipore Bioscience Research Reagents), SW rabbit (Rb) α-GnRH-1
(1:6000, Susan Wray, NIH), rabbit (Rb) α-active caspace-3 (1:1000, Millipore Bioscience
Research Reagents). After primary antibodies, sections were incubated in secondary
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antibody for 1-2 hours. The secondary antibody that was used is a biotinylated Donkeyα-Rabbit (Jackson Labs, 1:500). Sections were incubated in a horse-radish peroxidase
detection kit (Vector Labs) for 1 hour. Staining was detected using a DAB solution that
contained glucose and glucose oxidase and counterstained with methyl green for 30
seconds. Sections were mounted using Sub-X mounting (EMS). Epiflourescence and
brightfield pictures were taken on a Leica DM4000 B LED fluorescence microscope
equipped with a Leica DFC310 FX camera. Images were further analyzed using
FIJ/ImageJ software.
Immunofluorescence (IF)
Immunoflourscent staining was preformed the same way as IHC with the
exception of the initial hydrogen peroxide solution incubation. The primary antibodies
that were used are chicken (Chk) α-Peripherin (1:1500, Abcam), Rabbit (Rb) α-GnRH-1
(1:6000, Susan Wray, NIH), goat (Gt) α-Neuropilin-2 (1:3000, R&D Systems), and goat
(Gt) α-Olfactory Marker Protein (OMP) (1:4000, WAKO). Αntigen retrieval was performed
in a citric acid solution prior to incubation with chicken α-Peripherin. After primary
antibodies, sections were washed in 1x PBS and incubated in the secondary antibody
for 1½ hour. Species appropriate secondary antibodies were conjugated with Alexa-488
and Alexa-594 (Molecular Probes and Jackson Laboratories). Sections were
counterstained with DAPI (4’, 6’ –diamidino-2-phenylindole; 1:3000, Sigma-Aldrich) for 3
minutes, dried, and cover slipped with Fluoro Gel (Electron Microscopy Services).
Confocal microscopy pictures were taken on a Zeiss LSM 710 microscope.
Epiflourescence pictures were taken on a Leica DM4000 B LED fluorescence
microscope equipped with a Leica DFC310 FX camera. Images were further analyzed
using FIJ/ImageJ software.

8

Quαntification and statistical analyses of microscopy data
Cell counts were done on serial sections immunostained for GnRH-1 and
visualized under epiflourescence illumination (10X, 20X, 40X; Leica DM4000 B LED),
according to their anatomical location [i.e., (1) nasal area (VNO, axonal tracks
surrounding the olfactory pits); (2) forebrain junction (FBJ); and (3) brain]. For each
animal, counts were performed on 2 non-serial series. The average number of cells from
these 2 series was then multiplied by the total number of series per animal to compute a
value for each animal. These were then averaged (± standard error) among animals of
the same age and genotype. Means ±SEs were calculated on at least two animals per
genotype.
To generate GnRH-1 cell counts based on distance from the VNO, we measured
the distance from the center of the VNO to the base of the basal forebrain subdividing
the nasal area into 150-micron intervals. GnRH-1ns (GnRH-1 neurons) were counted in
each interval, with any GnRH-1ns in the brain counted towards ‘brain’.
Results
Ptch-2 is expressed along the GnRH-1 migratory tract
Hedgehog (Hh) functions by binding its transmembrane receptor proteins,
Patched-1 (Ptch-1) and Patched-2 (Ptch-2). By analyzing the publically available images

Figure 1. (A) Image taken from GENSAT
website of Ptch-2 EGFP BAC transgenic (B)
Blow up of area indicated in (A) showing
EGFP positive cell bodies (black arrow
heads) in the migratory tract (C,D,E) IF
staining against Ptch-2 (green) and tdTomato
(red) on a GnRHCre/R26tdTomato and DAPI
(blue). Co-localization of Ptch-2 and tdTomato
positive cell bodies (white arrows). Ptch-2
positive fibers (white arrow heads).
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of the BAC transgenic reporters generated by the GENSAT consortium (IHC available
on gensat.org), we identified that Ptch-2 is expressed by cells along the GnRH-1
migratory pathway (Fig.1A,B). Performing an immunofluorescent staining against
Patched-2 on GnRHCre/R26tdTomato reveled Patched-2 expression in the GnRH-1
neurons and along the fibers of the terminal nerve (TN).
GnRH-1 neurons do not access the brain in Gli3Xt/Xt mutants
GnRH-1 neurons are generated in the VNO between embryonic day 10.5 and
11.5 (E10-11.5) and finish their migration into the brain during embryonic development
by E18.5 (P. E. Forni, Bharti, Flannery, Shimogori, & Wray, 2013; Jasoni, Porteous, &
Herbison, 2009). To investigate whether a disrupted Gli3 protein, which is downstream
of Shh and Ptch2 signaling, can disrupt GnRH-1 neuronal migration we utilized Gli3Xt/Xt
mutants at E13.5 and E15.0.
E13.5 and E15.0 sections were immunostained against GnRH-1. In the E13.5
wildtype (WT), the majority of the GnRH-1ns were found in the nasal area (NA), while
the expected one-third of the population was found in the brain (Fig.2C). In the E13.5

Figure 2. IHC against GnRH on
E13.5 WT (A) and mutant (B) Blow
up of area indicated in (A) showing
GnRH-1ns in the brain (arrows) in
the WT (A’) and the mutant (B’)
GnRH counts at E13.5 (C) and E15.0
(D)
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mutant mice, we found that 64% of the total GnRH-1ns (n=2) were stuck proximal to the
VNO as compared to 43% in the WT. Interestingly there was a dramatic reduction in the
number of GnRH-1ns able to access the brain in the mutants (Fig 2B and D). There was
a 23% reduction of the total GnRH-1ns, as well, (n=2) (Fig.2A and C) indicating either
cell death or a reduction in neurogenesis. At E15.0, we see a similar phenotype to
E13.5, whereas in the WTs, we see GnRH-1ns accessing the brain, no GnRH-1 neurons
can be found in the brain of the mutant. (Fig.2D). We also observed that 59% of GnRH1ns were stuck in the NA compared to 12% in the WT, with a 38% total loss of GnRH1ns in the animal (n=2) (Fig.2D).
GnRH-1ns and its migratory scaffold get stuck proximal to the VNO
By

measuring

GnRH-1

neuronal

migration from the VNO to the brain, we
observed that the majority of the GnRH-1
neurons in the Gli3Xt/Xt mutants were unable
to go further than 300µm from the VNO,
whereas in the WT, GnRH-1ns were found
as far as the brain in the both E13.5 and
E15.0
(Fig.3C

and

D). Notably,
a

small

group
Figure 3. IHC against GnRH on E13.5 WT (A) and mutant (B) IHC against Peripherin on
E13.5 WT (A’) and mutant (B’) Arrows pointing to GnRH-1ns (A and B), and Peripherin
(A’ and B’) GnRH neuronal migration from VNO measured in E13.5 WT and mutant (C)
and E15.0 WT and mutant (D)

of

GnRH-1
neurons was
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consistently found to behave differently from the GnRH-1ns stuck in the tangles proximal
to the VNO. There is a distinct group of GnRH-1ns in the mutants that are found as far
as 750um from the VNO, which is where the olfactory bulb (OB) is normally found
(Fig.3C).
Peripherin is an intermediate filament expressed by the peripheral nervous
system, which can highlight the terminal nerve (Fig. 4A). Gli3Xt/Xt mutants form Peripherin
positive tangles near the VNO and in the FBJ (Fig.3B’), whereas in the WT, we see
Peripherin positive fibers projecting towards the brain (Fig.3A’). Most of the GnRH-1ns
form tangles proximal to the VNO (Fig3 C, D), which mirrors the Peripherin positive
tangles. This suggests that a nonfunctional Gli3 protein affects TN projection and GnRH1 neuronal migration. However, Peripherin is not specific and also highlights
vomeronasal and olfactory fibers.

Figure 4. IF staining against Peripherin (green) and OMP (red) on E15.0 WT (A) and mutant (B)
Arrow heads point to TN (A) Arrows point to fibrocellular mass (FCM) (B)

To differentiate between olfactory and TN projections we did an IF staining for
olfactory marker protein (OMP), which highlights olfactory neurons and their projections,
and Peripherin on E15.0 WT and mutant sections. The TN can be seen in the WT as
OMP negative, Peripherin positive and accessing the brain (Fig.4A), while in the KO
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there are no Peripherin positive fibers accessing the brain and no distinction in the
fibrocellular mass (FCM) between Peripherin only and OMP only fibers (Fig.4B).
In order to assess whether GnRH-1ns are actually tangling on the TN, we used
Neuropilin-2 (Nrp2), a known marker for vomeronasal projections (Casoni et al., 2016),
to differentiate between the TN and vomeronasal fibers. Under WT conditions, in the NA
we see that GnRH-1ns are migrating towards the brain on Nrp2 positive, Peripherin
positive TN bundles (Fig.5A and A’). However, we observed that the GnRH-1ns access
the brain on Peripherin positive, Nrp2 negative fibers (Fig.5B and B’), which is indicative
of the TN. When we look at the mutants, we see GnRH-1 neuronal tangles in the nasal
area on Peripherin positive, Nrp2 negative fibers (Fig.5C and C’) suggesting that GnRH1ns get stuck on the putative TN and not on vomeronasal fibers. We see something
similar in the FBJ of mutants, where GnRH-1ns are stuck on Peripherin positive, Nrp2
negative fibers (Fig5.D and D’). This further confirms that the TN is genetically distinct
from olfactory and vomeronasal fibers. This data suggests that the Gli3 mutation and

Figure 5. IHC against GnRH on E15.0 WT (A and B) and mutant (C and D) IF against Peripherin
(green) and Nrp2 (red) on E15.0 WT (A’ and B’) and mutant (C’ and D’) Arrows point to GnRH-1ns
in A,B,C,D. TN represented by arrows pointing to Peripherin positive, Nrp2 negative fibers in
A’,B’,C’,D’
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impaired Shh signaling affects the TN which plays a major role in GnRH-1 neuronal
migration.

Figure 6. Confocal images of E15.0 WT (A) and mutant (B) immunostained against GnRH
(red), Peripherin (green), and Nrp2 (white) Arrows point to TN

A triple immunostaining against GnRH, Peripherin, and Nrp2 done mostly to
recapture our previous observations that GnRH-1ns travel on the Peripherin positive,
Nrp2 negative TN (Fig6A,B) further confirms our hypothesis. In the mutant, we observed
the GnRH-1ns getting stuck in the FBJ on Peripherin positive, Nrp2 negative fibers,
indicating that the TN cannot enter the brain, forbidding GnRH-1ns from accessing the
brain (Fig.6B).
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The Terminal nerve has multiple branches
Under normal conditions, it has been recognized that a subset of GnRH-1ns form
a ‘ring of GnRH’ around the olfactory bulb (OB) (Casoni et al., 2016). Although we do
not consistently see such a neat streak of GnRH-1ns (Fig. 7B), we constantly observe a
few GnRH-1ns that make it further up the brain than the remaining bundle of GnRH-1ns
in the mutants (Fig.3 C-D). Interestingly enough, this is where the olfactory bulb (OB) is
normally found. We found that these GnRH-1ns are, as well, stuck on Peripherin
positive, Nrp2 negative fibers (Fig.6B). This may suggest that there is a branch of the
terminal nerve that, without fail, chooses this specific route, along with a subset of
GnRH-1ns that, accordingly, migrate along those fibers around the OB. In the mutant
mouse, we observed that this possible TN branch is still present and consistently takes
this alternate route. In addition, it is always accompanied by a subset of GnRH-1ns that
migrate along this putative branch of the TN (Fig.7B).

Figure 7. IHC against GnRH on E15.0 WT (A) and mutant (B) Arrows point to
GnRH-1ns showing GnRH-1ns surrounding OB (A)
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IF staining against Peripherin and Nrps2 highlights the two branches of the TN
diverging, where one is diving into the pre-optic area (POA) of the basal forebrain while
the other is projecting toward the OB (Fig.8A). IHC staining against GnRH shows two
populations of GnRH-1ns projecting to different areas of the brain on the differentiating
branches of the putative TN (Fig.8B).

Figure 8. IF staining against Peripherin (green) and Nrp2 (red) (A) and IHC
staining against GnRH (B) on E15.5 WT embryo. Arrows point to the two
branches of the diverging TN (A) and the GnRH-1ns migrating on the TN (B)

Gli3Xt/Wt Heterozygotes show haploinsufficiency
We were interested in studying GnRH-1 migration in heterozygotes because they
show a general phenotype of an extra toe. Homozygous mutants show no GnRH-1
neuronal access to the brain, yet heterozygotes are viable and fertile, suggesting their
anatomy to mirror a WT. As expected, GnRH-1ns do enter the brain, however, it is a
reduced amount, an amount that is just enough to allow fertility. The reduced amount of
GnRH-1ns that access the brain in heterozygotes could be the cause of smaller litters
and slower weight gain during pregnancy.
Most noticeably, the TN in the heterozygotes enters the brain, but is shorter and
less branched (Fig.9B). In the WT, chemoattractants and repellants direct the projection
of the TN into the pre-optic area (POA) of the basal forebrain, which allows the migration
of the GnRH-1ns into the POA (Fig.9A and A’). In the heterozygote, the TN does not
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extend into the POA and the GnRH-1ns just make it into the brain but do not reach the
POA (Fig.9B and B’). From our GnRH-1 cell quantifications, we observed a total number
of GnRH-1ns that is similar to the WT. However, there was a significant reduction of
GnRH-1ns that entered the brain (Fig.9D), further confirming that heterozygotes show an
intermediate phenotype, or haploinsufficiency.
To confirm if this phenotype is a real result, we looked at postnatal day zero (P0)
Gli3Xt/Wt heterozygote mutants. Due to animal mating issues, we were unable to get
ample embryos to complete an n=3 for all ages we tested. As a majority of GnRH-1ns
finish their migration
into the POA by
E16.5 (P. E. Forni,
Bharti,

Flannery,

Shimogori, & Wray,
2013), and since we
saw

that

the

P0

GnRH-1 cell counts
were similar to our
E15.5 heterozygous
counts,

we

were

able to combine our
E15.5

and

P0

counts to test for
Wt/Wt

Figure 9. IF staining against Peripherin and Nrp2 on E13.5 Gli3
Xt/Wt
Wt/Wt
(A) and Gli3
(B) IHC staining against GnRH on E13.5 Gli3
Xt/Wt
(A’) and Gli3
(B’) White arrows point to vomeronasal fibers
(VNF) and the TN (A and B) Black arrows point to GnRH-1ns (A’
Wt/Wt
Xt/Wt
and B’) Cell counts of E13.5 Gli3
and Gli3
(Nasal P=0.306;
Wt/Wt
FBJ P=0.761; Brain P=0.112) (C) and E15.5 & P0 Gli3
and
Xt/Wt
Gli3
(Nasal P=0.582; FBJ P=0.426; Brain P<0.0001) (D)

any

significant

difference. With an
n=4

for
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heterozygous mutants, our t-test evaluation showed that there was a significant
reduction of GnRH-1ns accessing the brain (P<0.0001) (Fig.9D).
Interestingly, at E13.5, our results were variable. We saw less total GnRH-1ns
than we did in mutants of the same age. However, we saw no significant difference
between the WT and the heterozygote; this could be due to loss of sections.
Discussion
After characterizing two different ages, E13.5 and E15.0, we can conclude that
an impaired Shh signaling pathway and a nonfunctional Gli3 protein causes severe
developmental delay and defected GnRH-1 neuronal migration. Interestingly, we see an
overall reduction in the number of GnRH-1 neurons but did not see a difference in
cleaved-caspase-3, a marker for cell death, (Data not shown n=1) but this will need to be
further characterized, as no quantifications were made. However, we did notice a
reduction in the volume of the olfactory epithelium (OE) (Data not shown n=1), which
may be due to a developmental delay. In an immunostaining against OMP, we confirmed
that the reduction in OE volume resulted in a decreased number of mature olfactory
neurons (OMP+ cells) in the OE. This further suggests that the Gli3 mutation either
affects neurogenesis or differentiation of neurons into mature olfactory neurons.
Our stainings also confirm that GnRH-1ns enter the brain on Peripherin
positive fibers that are also negative for Nrp2 (vomeronasal fiber marker) and OMP
(olfactory fiber marker). In the mutants, we see GnRH-1ns forming tangles only on
Peripherin positive fibers near the VNO and in the FBJ. This suggests to us that the
GnRH-1ns migration is affected by the Gli3 mutation since both the TN and the GnRH1ns are aberrant. One of our future goals is to find a marker for the TN. This will allow us
to accurately depict the effects of a nonfunctional GLI3 and an impaired Shh signaling

18

pathway on TN projections. One potential marker we are currently testing is Calbindin,
which is a calcium binding protein. We see that Calbindin is expressed along the
migratory route of the GnRH-1ns. Thus far, GnRH-1ns seem to be negative for
Calbindin, suggesting the expression may be highlighting the probable TN.
In the Gli3Xt/Wt embryos, an intermediate phenotype between the WT and mutant
was observed; that led us to conclude that this is a phenomenon of haploinsufficiency,
where one copy of the Gli3 gene does not produce enough of the Gli3 protein to mirror
the wild type phenotype. We see with Peripherin IF that the TN is unable to fully branch
and dive into the POA of the basal forebrain, and also, interestingly see a reduction in
the number of GnRH-1ns in the brain. This could suggest that Gli3 may affect the fine
targeting of the TN which may alter the GnRH-1 neuronal migratory route, which may
causes HH in humans. This may explain the slow weight gain of pregnant Gli3Xt/Wt mice
and the small litters we collect with Gli3 matings. Although the E15.5 heterozygote
counts mirrored our expectations, one thing we need to investigate in the future is why
there was a total decrease in GnRH-1ns in the E13.5 heterozygotes, even compared to
the E13.5 homozygous mutants. Though when put through a t-test, the overall number
of GnRH-1ns is seen as an insignificant difference (n=2) (Nasal P=0.306; FBJ P=0.761;
Brain P=0.112). This we believe is the result of lost sections during sectioning, so we will
need to increase our sample size and exclude some of the previous data.
The heterozygote characterizations also confirm the connection between Gli3
and Shh and its effects on the migration of GnRH-1ns and the projections of the TN.
Heterozygotes are missing one functional Gli3 gene and have less of the Gli3 protein,
which naturally acts as a transcriptional repressor, so we may be seeing an
overexpression of downstream genes. Previous literature has shown how Shh signaling
regulates neuropilin-1 (Nrp1) expression (Eisner et al., 2015), a receptor for a
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chemorepellant, which is expressed by the TN. This may tell us that the Gli3 gene and
the Shh pathway play a large role in projecting the TN to the correct area and directing
the migration of GnRH-1ns. With one copy of the Gli3 gene, there are still enough
GnRH-1ns accessing the brain to allow for sexual development, but we would like to
observe whether the heterozygous mutants go through puberty at later stages. This
condition mirrors the phenotype of KS patients, individuals presenting with HH and
anosmia. KS patients undergo a continuum of phenotypes. Some go through various
degrees of puberty at different ages, while others don’t undergo puberty at all and are
infertile. We will continue to study Gli3 mutants to better understand the KS phenotype,
while using the Gli3 heterozygotes to depict the affects of a nonfunctional Gli3 protein
and a defective Shh signaling pathway on TN projections and GnRH-1 neuronal
migration.
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